Efficacy and Safety of Sofosbuvir and Ribavirin for Treating Chronic Hepatitis C, Genotype 3: Experience of a Tertiary Care Hospital at Karachi, Pakistan

Background It is estimated that approximately 10 million individuals in Pakistan are infected with hepatitis C virus (HCV). Historically, it was very difficult not just to cure but even treat HCV as available options did not have desirable outcomes. However, the approval of directly acting antiviral...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cureus
Главные авторы: Butt, Nazish, Reema, Sehrish, Ali Khan, M, Abbasi, Amanullah, Butt, Sehrish, Khoso, Mohammad M, Akbar, Ali, Haleem, Farhan, Mahesar, Ghulam B, Fahad, Anoshia, Qureshi, Talha
Формат: Artigo
Язык:Inglês
Опубликовано: Cureus 2019
Предметы:
Gastroenterology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6561614/
https://ncbi.nlm.nih.gov/pubmed/31205844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.4458
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы